(+/-)-beta-Phenylisopropylamine en es it fr

(+/-)-beta-Phenylisopropylamine Brand names, (+/-)-beta-Phenylisopropylamine Analogs

(+/-)-beta-Phenylisopropylamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

(+/-)-beta-Phenylisopropylamine Chemical_Formula

C9H13N

(+/-)-beta-Phenylisopropylamine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

(+/-)-beta-Phenylisopropylamine fda sheet

(+/-)-beta-Phenylisopropylamine msds (material safety sheet)

(+/-)-beta-Phenylisopropylamine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

(+/-)-beta-Phenylisopropylamine Molecular Weight

135.206 g/mol

(+/-)-beta-Phenylisopropylamine Melting Point

Volatizes slowly at room temperature

(+/-)-beta-Phenylisopropylamine H2O Solubility

Slightly

(+/-)-beta-Phenylisopropylamine State

Solid

(+/-)-beta-Phenylisopropylamine LogP

1.799

(+/-)-beta-Phenylisopropylamine Dosage Forms

Capsules

(+/-)-beta-Phenylisopropylamine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

(+/-)-beta-Phenylisopropylamine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

(+/-)-beta-Phenylisopropylamine Absorption

It forms easily absorbed molecules that are highly lipid soluble

(+/-)-beta-Phenylisopropylamine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

(+/-)-beta-Phenylisopropylamine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

(+/-)-beta-Phenylisopropylamine Organisms Affected

Humans and other mammals